Costimulation Blockade in the Treatment of Rheumatic Diseases

@article{Liossis2012CostimulationBI,
  title={Costimulation Blockade in the Treatment of Rheumatic Diseases},
  author={S. Liossis and P. Sfikakis},
  journal={BioDrugs},
  year={2012},
  volume={18},
  pages={95-102}
}
The autoimmune response is executed via cognate interactions between effector immune cells and antigen presenting cells. Cognate interactions provide the immune effectors with specific signals generated through the antigen receptor as well as with second, non-specific signals, generated from the interaction of pairs of cell-surface molecules (costimulatory molecules) present on their plasma membrane. Disruption of this second, non-specific costimulatory signal results in the interruption of the… Expand
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
Importance of reverse signaling of the TNF superfamily in immune regulation
B cell therapies for rheumatoid arthritis: beyond B cell depletion.
Pharmacological Effects and Mechanisms of Action of Agents Blocking B Cells
...
1
2
3
...

References

SHOWING 1-10 OF 88 REFERENCES
Treatment of murine lupus with CTLA4Ig.
Adhesion and Costimulatory Molecules
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Inducible costimulator is essential for collagen-induced arthritis.
CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
...
1
2
3
4
5
...